Work

Статины и риск развития сахарного диабета

Year: 2012

Type: article

Abstract: Randomized controlled trials have clearly demonstrated the efficacy of statins in reduction of serum low density lipoprotein cholesterol level by 25-50% from the baseline. Statins may increase the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action is statins class effect and does not depend on their hydrophobic or hydrophilic properties. However, the use of statins in patients with DM is obligatory. The statins diabetogenic risk is exaggerated and we will continue to treat our patients with statins.

Source: DOAJ (DOAJ: Directory of Open Access Journals)

DOI: 10.1234/1819-6446-2013-4-444-447

Authors: О. М. Драпкина, М. В. Костюкевич

Institution: Sechenov University

Language: Russian

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2130387887

FWCI:

Cites: 22

Cited by:

Related to: 10